Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis

INTRODUCTION: Crisaborole topical ointment, 2%, is a nonsteroidal, topical anti-inflammatory phosphodiesterase-4 (PDE4) inhibitor that is approved for the treatment of mild-to-moderate atopic dermatitis (AD). The objective of the current analysis was to compare the efficacy of crisaborole 2% relativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Thom, Howard, Cheng, Vincent, Keeney, Edna, Neary, Maureen P., Eccleston, Anthony, Zang, Chuanbo, Cappelleri, Joseph C., Cha, Amy, Thyssen, Jacob P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776944/
https://www.ncbi.nlm.nih.gov/pubmed/34877623
http://dx.doi.org/10.1007/s13555-021-00646-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776944/
https://www.ncbi.nlm.nih.gov/pubmed/34877623
http://dx.doi.org/10.1007/s13555-021-00646-1

Ejemplares similares